ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,670Medicare Part D Prescriptions Filled, Including Refills

Rank: 45 out of 229

$401K Total Retail Price of All Prescriptions

Rank: 69 out of 229

351 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

16% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 7,500 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 330 307 1 1
LISINOPRIL 329 306 2 2
METFORMIN HCL 310 255 3 6
HYDROCODONE-ACETAMINOPHEN 285 192 S3 4 7
SIMVASTATIN 277 271 5 3
OMEPRAZOLE 267 231 6 4
AMLODIPINE BESYLATE 255 233 7 5
FUROSEMIDE 227 207 8 8
POTASSIUM CHLORIDE 212 184 9 18
WARFARIN SODIUM 205 194 10 17
HYDROCHLOROTHIAZIDE 156 133 11 9
METOPROLOL TARTRATE 116 109 12 13
DIOVAN 115 105 13 42
LOSARTAN POTASSIUM 113 113 14 12
FAMOTIDINE 107 88 15 84
DOXAZOSIN MESYLATE 107 84 15 50
CARVEDILOL 105 105 17 31
PREDNISONE 101 95 18 35
ENALAPRIL MALEATE 100 82 19 54
LEVOXYL 97 95 20 148
TAMSULOSIN HCL 94 82 21 24
ZOLPIDEM TARTRATE 94 77 21 20
MELOXICAM 93 87 23 45
SPIRONOLACTONE 92 75 24 56
PANTOPRAZOLE SODIUM 89 87 25 33
METOPROLOL SUCCINATE 80 65 26 16
NEXIUM 80 66 26 48
SERTRALINE HCL 77 61 28 22
CELEBREX 75 73 29 71
GLYBURIDE 72 59 R 30 57
LOVASTATIN 72 65 30 11
SYNTHROID 71 71 32 46
RANITIDINE HCL 70 41 33 32
TRAMADOL HCL 68 67 34 26
ALLOPURINOL 65 63 35 27
LOSARTAN-HYDROCHLOROTHIAZIDE 60 53 36 65
ATORVASTATIN CALCIUM 59 48 37 15
FELODIPINE ER 58 58 38 61
QUINAPRIL HCL 58 46 38 278
CITALOPRAM HBR 54 46 40 21
AMLODIPINE BESYLATE-BENAZEPRIL 53 52 41 120
BENAZEPRIL HCL 53 51 41 86
GABAPENTIN 52 46 43 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 40 43 28
MIRTAZAPINE 52 51 43 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.